Robeco Institutional Asset Management B.V.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1418773
ROTTERDAM, P7
Position in VRTX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$200,875,625
+$21,525,514 QoQ
Shares Held
404,396
+0.7% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#72
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $992,672,242 across 15 Biotechnology names. VRTX ranks #3 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
460,602 | $287,203,771 | |
| 2 | INCY |
Incyte Corp
|
2,441,735 | $276,795,079 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
404,396 | $200,875,625 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
188,084 | $56,618,926 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,029,819 | $56,032,451 | |
| 6 | RPRX |
Royalty Pharma plc
|
911,586 | $51,112,627 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
117,612 | $28,340,963 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
408,215 | $23,358,062 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,875,625 | 404,396 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $179,350,111 | 401,644 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $178,714,512 | 394,200 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $148,576,858 | 379,371 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $146,644,873 | 329,391 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $70,783,720 | 146,000 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $115,476,641 | 286,756 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $137,927,845 | 296,568 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $173,525,299 | 370,211 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $193,901,880 | 463,869 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $186,284,007 | 457,824 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $150,549,512 | 432,937 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $143,021,150 | 406,414 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $140,778,632 | 446,817 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $136,291,742 | 471,957 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $98,162,746 | 339,030 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $71,582,268 | 254,027 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $61,806,047 | 236,832 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $43,550,632 | 198,318 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $36,814,007 | 202,955 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $40,948,431 | 203,087 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $37,926,365 | 176,492 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $68,183,380 | 288,497 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $96,844,514 | 355,889 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $89,517,669 | 308,352 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $19,029,575 | 79,973 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||